Novo Integrated Sciences Revenue 2012-2024 | NVOS

Novo Integrated Sciences revenue from 2012 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Novo Integrated Sciences Annual Revenue
(Millions of US $)
2023 $13
2022 $12
2021 $9
2020 $8
2019 $9
2018 $9
2017 $8
2016 $
2016 $7
2015 $
2014 $
2013 $
2012 $
2012 $
2011 $
2011 $
Novo Integrated Sciences Quarterly Revenue
(Millions of US $)
2024-05-31 $3
2024-02-29 $3
2023-11-30 $4
2023-08-31 $3
2023-05-31 $3
2023-02-28 $3
2022-11-30 $3
2022-08-31 $-8
2022-05-31 $14
2022-02-28 $3
2021-11-30 $3
2021-08-31 $3
2021-05-31 $2
2021-02-28 $2
2020-11-30 $2
2020-08-31 $2
2020-05-31 $1
2020-02-29 $2
2019-11-30 $3
2019-08-31 $2
2019-05-31 $2
2019-02-28 $2
2018-11-30 $2
2018-08-31 $2
2018-05-31 $2
2018-02-28 $2
2017-11-30 $2
2017-08-31 $2
2017-05-31 $2
2017-03-31
2017-02-28 $2
2016-12-31
2016-11-30 $2
2016-09-30
2016-06-30
2016-05-31 $2
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-08-31
2012-06-30
2012-03-31
2012-02-29
2011-12-31
2011-11-30
2011-09-30
2011-08-31
2011-06-30
2011-05-31
2011-03-31
2011-02-28
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.006B $0.013B
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.223B 12.84
Quest Diagnostics (DGX) United States $17.268B 17.71
DaVita (DVA) United States $13.687B 16.84
Encompass Health (EHC) United States $9.264B 22.79
Chemed (CHE) United States $8.808B 27.08
Elanco Animal Health (ELAN) United States $7.449B 16.74
Option Care Health (OPCH) United States $5.396B 26.51
RadNet (RDNT) United States $5.150B 122.18
Amedisys (AMED) United States $3.183B 22.77
Astrana Health (ASTH) United States $2.839B 40.17
LifeStance Health (LFST) United States $2.625B 0.00
Addus HomeCare (ADUS) United States $2.408B 29.24
U.S Physical Therapy (USPH) United States $1.282B 34.70
Pennant (PNTG) United States $1.076B 51.61
Aveanna Healthcare Holdings (AVAH) United States $1.063B 0.00
Atai Life Sciences (ATAI) Germany $0.211B 0.00
Daxor (DXR) United States $0.044B 0.00
ATI Physical Therapy (ATIP) United States $0.025B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00